Abstract
Although the standard treatment for patients with N2 non-small-cell lung cancer (NSCLC) is definitive chemoradiation, several studies have demonstrated that minimal N2 disease, such as single-station N2 disease (N2 disease limited to a single mediastinal station), is a favorable prognostic indicator of resected N2 NSCLC. The objective of this study is to investigate long-term survival outcomes and develop a risk model for multiple-station N2 metastasis in patients with clinical single-station N2 NSCLC.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
